Edition:
India

Mabion SA (MABP.WA)

MABP.WA on Warsaw Stock Exchange

78.00PLN
25 Mar 2019
Change (% chg)

-- (--)
Prev Close
78.00zł
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,700
52-wk High
124.00zł
52-wk Low
66.00zł

About

Mabion SA is a Poland-based company engaged in the research and development of biotechnological and biopharmaceutical medicinal products. Mabion SA was founded by four pharmaceutical companies, including Celon Pharma Ltd, Polfarmex Co, Genexo Ltd and IBSS Biomed Co, as well as two companies focused on research and development in... (more)

Overall

Beta: 0.80
Market Cap(Mil.): zł1,233.10
Shares Outstanding(Mil.): 11.80
Dividend: --
Yield (%): --

Financials

BRIEF- Mabion Q3 Net Loss Narrows To 11.1 Mln Zlotys

* SAID ON THURSDAY Q3 NET LOSS WAS AT 11.1 MLN ZLOTYS VS LOSS OF 13.2 MLN ZLOTYS YR AGO

16 Nov 2018

BRIEF-Mabion Files Second Patent Application

* SAID ON FRIDAY IT FILED A SECOND PATENT APPLICATION FOR ITS INVENTION FROM AREA OF ​​APPLICATION OF MABIONCD20 IN TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS 'LOW AGGREGATE ANTI CD20 LIGAND FORMULATION'

29 Oct 2018

Earnings vs. Estimates